(株)中京医薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4558/E03289 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/04/05 | 日証協 | 511,900株 | -0.54% | 0株 | -100% | 1,024,955株 | +105.05% | 19,180株 | -96.37% |
| 2024/03/29 | 日証協 | 514,700株 | +1.22% | 24,900株 | +36.81% | 499,854株 | -51.61% | 528,923株 | +2640.53% |
| 2024/03/22 | 日証協 | 508,500株 | -4.58% | 18,200株 | -54.84% | 1,032,980株 | -2.36% | 19,300株 | -16.09% |
| 2024/03/15 | 日証協 | 532,900株 | +0.62% | 40,300株 | +452.05% | 1,057,980株 | -0.85% | 23,001株 | +50.33% |
| 2024/03/08 | 日証協 | 529,600株 | -2.13% | 7,300株 | -79.08% | 1,067,079株 | -0.53% | 15,300株 | -6.14% |
| 2024/03/01 | 日証協 | 541,100株 | -0.61% | 34,900株 | 0% | 1,072,779株 | +0.31% | 16,301株 | +150.78% |
| 2024/02/22 | 日証協 | 544,400株 | -0.38% | 0株 | -100% | 1,069,479株 | +0.45% | 6,500株 | -84.18% |
| 2024/02/16 | 日証協 | 546,500株 | +1.84% | 66,200株 | -6.76% | 1,064,679株 | +0.98% | 41,100株 | -29.5% |
| 2024/02/09 | 日証協 | 536,600株 | +11.95% | 71,000株 | 0% | 1,054,379株 | +2.86% | 58,300株 | +555.06% |
| 2024/02/02 | 日証協 | 479,300株 | -0.37% | 0株 | 0% | 1,025,080株 | +0.37% | 8,900株 | -19.1% |
| 2024/01/26 | 日証協 | 481,100株 | 0% | 0株 | -100% | 1,021,279株 | +0.75% | 11,001株 | +3.78% |
| 2024/01/19 | 日証協 | 481,100株 | -0.27% | 1,600株 | 0% | 1,013,679株 | +0.62% | 10,600株 | +34.18% |
| 2024/01/12 | 日証協 | 482,400株 | -0.04% | 0株 | -100% | 1,007,479株 | +0.43% | 7,900株 | -48.37% |
| 2024/01/05 | 日証協 | 482,600株 | -0.12% | 7,000株 | -77.64% | 1,003,180株 | +0.49% | 15,300株 | -75.61% |
| 2023/12/29 | 日証協 | 483,200株 | -1.15% | 31,300株 | +198.1% | 998,271株 | +0.04% | 62,731株 | +13.23% |
| 2023/12/22 | 日証協 | 488,800株 | -3.07% | 10,500株 | +9999.99% | 997,859株 | -0.21% | 55,400株 | +477.08% |
| 2023/12/15 | 日証協 | 504,300株 | -0.02% | 100株 | -99.73% | 999,959株 | +0.26% | 9,600株 | -67.89% |
| 2023/12/08 | 日証協 | 504,400株 | +4.82% | 37,200株 | 0% | 997,410株 | +2.26% | 29,900株 | +35.91% |
| 2023/12/01 | 日証協 | 481,200株 | -1.76% | 0株 | -100% | 975,410株 | -0.7% | 22,000株 | -60.64% |
※株式分割は考慮していませんのでご注意ください。
Page Top